No image set

Pulmonologists as the Gatekeepers of Precision Medicine


Activity Info

Presented by: Momen M. Wahidi, MD, FCCP and W. Dean Wallace, MD

Biomarker-driven targeted therapy of patients with NSCLC requires accurate diagnosis and staging. The pulmonary care team must acquire adequate biopsy tissue to enable histology, immunofluorescence and molecular biomarker testing.

Presented in Los Angeles, California - October 2016.
Digital Download

Pulmonologists as the Gatekeepers of Precision Medicine: How Much is Enough Tissue?
This activity is a downloadable file. You must add it to your course history to access the file. Click


Pulmonary | Oncology | Pathology | Nurse | Nurse Practitioner | Idiopathic Pulmonary Fibrosis | PILOTforPulmonary.org | Slides | 

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA